openPR Logo
Press release

Gene Delivery System Market Outlook 2031: From US$ 5.4 Billion in 2022 to US$ 10.0 Billion by 2031, Driven by Advances in Gene Therapy and Rising Disease Prevalence

07-07-2025 08:25 AM CET | Health & Medicine

Press release from: Transparency Market Research

Gene Delivery System Market

Gene Delivery System Market

The global Gene Delivery System Market, valued at US$ 5.4 billion in 2022, is projected to grow at a compound annual growth rate (CAGR) of 7.2% from 2023 to 2031, reaching US$ 10.0 billion by 2031. Gene delivery systems, including viral vectors, non-viral vectors, and physical methods, enable the transfer of therapeutic genes to treat genetic disorders, cancers, and infectious diseases. The market's growth is driven by advancements in gene therapy, increasing prevalence of chronic diseases, and rising R&D investments. However, challenges such as high costs, regulatory complexities, and safety concerns persist. This report provides a comprehensive analysis of the market, covering its overview, key drivers, challenges, regional insights, and future opportunities.

Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=41636

Market Overview

The Gene Delivery System Market encompasses viral vectors (e.g., adeno-associated viruses, lentiviruses), non-viral vectors (e.g., liposomes, nanoparticles), and physical methods (e.g., electroporation) for gene therapy applications. Valued at US$ 5.4 billion in 2022, the market is expected to reach US$ 10.0 billion by 2031, driven by a CAGR of 7.2%. It is segmented by delivery system (viral, non-viral, physical), application (oncology, genetic disorders, infectious diseases, others), end-user (hospitals, research institutes, biotech companies), and region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa). Viral vectors dominate due to their high efficiency, while research institutes lead as end-users.

Key Drivers of Growth

Several factors are propelling the growth of the Gene Delivery System Market:

Advancements in Gene Therapy: Over 20 gene therapies approved globally by 2023, including Zolgensma and Luxturna, drive demand for efficient delivery systems.

Rising Prevalence of Chronic Diseases: Increasing cases of cancer (19.3 million new cases in 2020) and genetic disorders fuel the need for targeted gene therapies.

Growing R&D Investments: Global gene therapy R&D spending, reaching US$ 9.6 billion in 2022, supports innovation in delivery systems.

Regulatory Support: Fast-track approvals and orphan drug designations by the FDA and EMA accelerate market entry for gene therapies.

Technological Innovations: Improvements in CRISPR-based editing and non-viral vectors enhance delivery efficiency, boosting market adoption.

Top Companies:

Novartis AG
Amgen Inc.
Oxford Biomedica PLC
Sibiono GeneTech Co., Ltd.
Shanghai Sunway Biotech Co., Ltd.
Pfizer, Inc.
Bayer AG
Johnson & Johnson Services, Inc.
Human Stem Cells Institute

Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/gene-delivery-system-market.html

Challenges and Barriers

Despite its growth potential, the market faces several challenges:

High Development Costs: Gene delivery systems, especially viral vectors, cost millions to develop, limiting accessibility in low-income regions.

Regulatory Complexities: Stringent regulations for gene therapies, requiring extensive clinical trials, increase costs and delay approvals.

Safety Concerns: Risks like immune responses or off-target effects with viral vectors may reduce patient and clinician confidence.

Limited Infrastructure in Developing Regions: Inadequate biotech facilities in Africa and parts of Asia-Pacific restrict market penetration.

Scalability Issues: Manufacturing challenges for viral vectors, such as low yield and high complexity, hinder large-scale production.

Regional Insights

The Gene Delivery System Market exhibits distinct regional dynamics:

North America: North America dominates, with a 45% share in 2022, driven by advanced biotech infrastructure, high R&D funding, and FDA approvals. The U.S. leads due to its robust gene therapy ecosystem.

Europe: Europe holds a significant share, with Germany, France, and the UK benefiting from strong research networks and supportive regulations.

Asia-Pacific: Asia-Pacific is expected to witness rapid growth, fueled by increasing biotech investments, rising disease prevalence, and clinical trials in China, Japan, and India.

Latin America: Latin America shows moderate growth, with Brazil and Mexico leading due to improving biotech infrastructure. Cost barriers limit adoption.

Middle East & Africa: This region has the smallest share due to limited biotech facilities. Growth opportunities exist in Gulf countries with rising investments.

Future Opportunities

The Gene Delivery System Market offers several avenues for growth and innovation:

Non-Viral Vector Development: Advancing non-viral systems like nanoparticles could reduce safety risks and improve scalability.

Expansion in Emerging Markets: Increasing biotech investments in Asia-Pacific and Latin America present opportunities for affordable delivery systems.

CRISPR and Gene Editing: Integrating advanced gene editing with efficient delivery systems could enhance therapeutic outcomes.

AI-Driven Optimization: AI for designing targeted delivery systems could improve precision and reduce development costs.

Partnerships with Biotech Firms: Collaborations can streamline R&D and manufacturing, expanding market reach.

Browse More Trending Research Reports:

Liquid Filled Hard Capsules Market: https://www.globenewswire.com/news-release/2023/7/4/2699010/0/en/Liquid-Filled-Hard-Capsules-Market-to-Grow-at-a-CAGR-of-7-8-from-2022-to-2031-reaching-US-4-0-billion-As-per-TMR-Study.html

Oral Rehydration Solution [ORS] Market: https://www.globenewswire.com/news-release/2023/10/05/2755222/32656/en/Oral-Rehydration-Solution-ORS-Market-to-Exceed-USD-6-71-billion-by-2031-Capturing-a-9-9-CAGR-TMR-Report.html

Atopic Dermatitis Drugs Market: https://www.globenewswire.com/news-release/2023/07/31/2715115/32656/en/Atopic-Dermatitis-Drugs-Market-to-Grow-at-a-CAGR-of-14-7-from-2022-to-2031-reaching-USD-29-4-Billion-As-per-TMR-Study.html

Oligonucleotides Market: https://www.globenewswire.com/news-release/2024/12/02/2989923/32656/en/Oligonucleotides-Market-Outlook-2034-Projected-to-Reach-US-13-1-Billion-by-2034-Driven-by-Expanding-Applications-in-Biotechnology-and-Precision-Medicine-TMR.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gene Delivery System Market Outlook 2031: From US$ 5.4 Billion in 2022 to US$ 10.0 Billion by 2031, Driven by Advances in Gene Therapy and Rising Disease Prevalence here

News-ID: 4093661 • Views:

More Releases from Transparency Market Research

Acromegaly Treatment Market to Reach USD 3.1 Billion by 2035, Driven by Diagnostic Advancements, Oral Drug Innovations, and Rising Disease Awareness | TMR
Acromegaly Treatment Market to Reach USD 3.1 Billion by 2035, Driven by Diagnost …
The global Acromegaly Treatment Market is experiencing a significant transformation as improved early diagnosis, innovative therapeutic formulations, and regulatory support converge to expand patient access and drive substantial growth. According to the latest industry analysis, the global market, valued at US$ 1.5 billion in 2024, is projected to reach US$ 3.1 billion by 2035, progressing at a CAGR of 6.7% from 2025 to 2035. Gain a preview of important insights from
Forensic Genomics Market Projected to Surge to USD 2.4 Billion by 2035 as NGS, AI/ML Bioinformatics and Portable DNA Devices Transform Criminal Investigations | TMR
Forensic Genomics Market Projected to Surge to USD 2.4 Billion by 2035 as NGS, A …
The global Forensic Genomics Market is undergoing a period of accelerated transformation and expansion as next-generation sequencing (NGS), advanced PCR workflows, and AI/ML-driven bioinformatics redefine the capabilities of modern forensic investigations. According to the latest industry analysis, the market-valued at US$ 0.5 billion in 2024-is projected to reach approximately US$ 2.4 billion by 2035, expanding at a compound annual growth rate (CAGR) of 14.5% between 2025 and 2035. Access key findings
Planetary Roller Screw Market to Reach USD 1.1 Billion by 2035 as Demand for High-Load, High-Precision Actuation Systems Accelerates Worldwide | TMR
Planetary Roller Screw Market to Reach USD 1.1 Billion by 2035 as Demand for Hig …
The global Planetary Roller Screw Market is poised for substantial expansion over the next decade, driven by rising demand for high-load, high-precision performance in harsh industrial environments, rapid technological advancements, and the ongoing global shift toward electrified and automated systems. According to the latest industry intelligence, the market-valued at US$ 610.0 Mn in 2024-is projected to reach US$ 1,105.0 Mn by 2035, advancing at a compound annual growth rate (CAGR)
Chemical Absorbent Cotton Market Set to Reach USD 600.1 Million by 2035 Driven by Sustainability Initiatives, Regulatory Compliance, and Rising Industrial Demand
Chemical Absorbent Cotton Market Set to Reach USD 600.1 Million by 2035 Driven b …
The global Chemical Absorbent Cotton Market is entering a phase of sustained expansion, backed by rapid industrialization, strengthened environmental regulations, and growing adoption of biodegradable absorbent solutions across healthcare, chemical handling, automotive, and industrial safety applications. According to the latest industry analysis, the global market-valued at US$ 340.0 million in 2024-is projected to reach US$ 600.1 million by 2035, expanding at a CAGR of 5.4% from 2025 to 2035. Access key

All 5 Releases


More Releases for Gene

DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034" The DNA and Gene Cloning Services Market Size is valued
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period? The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks. The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies. In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal